These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8390871)
1. Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters. Baumann KH; Kiesel L; Kaufmann M; Bastert G; Runnebaum B Breast Cancer Res Treat; 1993; 25(1):37-46. PubMed ID: 8390871 [TBL] [Abstract][Full Text] [Related]
2. Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells. Mullen P; Bramley T; Menzies G; Miller B Eur J Cancer; 1993; 29A(2):248-52. PubMed ID: 8380699 [TBL] [Abstract][Full Text] [Related]
3. [Gonadotropin-releasing hormone receptors in human breast cancer tissue]. Kiesel L; Kaufmann M; Haeseler F; Klinga K; von Holst T; Schmidt W; Runnebaum B Geburtshilfe Frauenheilkd; 1988 Jun; 48(6):420-4. PubMed ID: 2843413 [TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue. Sion-Vardi N; Kaneti J; Segal-Abramson T; Giat J; Levy J; Sharoni Y J Urol; 1992 Nov; 148(5):1568-70. PubMed ID: 1331544 [TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata. Wiznitzer A; Marbach M; Hazum E; Insler V; Sharoni Y; Levy J Biochem Biophys Res Commun; 1988 May; 152(3):1326-31. PubMed ID: 2837183 [TBL] [Abstract][Full Text] [Related]
6. Distribution of gonadrotropin releasing hormone agonist binding sites in the rat central nervous system. Jennes L; Dalati B; Conn PM Brain Res; 1988 Jun; 452(1-2):156-64. PubMed ID: 2841008 [TBL] [Abstract][Full Text] [Related]
7. Guanine nucleotide modulation of high affinity gonadotropin-releasing hormone receptors in rat mammary tumors. Segal-Abramson T; Giat J; Levy J; Sharoni Y Mol Cell Endocrinol; 1992 May; 85(1-2):109-16. PubMed ID: 1326449 [TBL] [Abstract][Full Text] [Related]
8. Effect of purified 31K bovine inhibin on the specific binding of gonadotropin-releasing hormone to rat anterior pituitary cells in culture. Wang QF; Farnworth PG; Findlay JK; Burger HG Endocrinology; 1988 Nov; 123(5):2161-6. PubMed ID: 2844504 [TBL] [Abstract][Full Text] [Related]
9. Effects of gonadotropin-releasing hormone agonist on steroidogenesis in the rat ovary. Mori H; Ohkawa T; Takada S; Morita T; Yago N; Arakawa S; Okinaga S Horm Res; 1994; 41 Suppl 1():14-21. PubMed ID: 8088692 [TBL] [Abstract][Full Text] [Related]
10. Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor-binding ability to rat pituitary and human breast cancer membranes. Fekete M; Bajusz S; Groot K; Csernus VJ; Schally AV Endocrinology; 1989 Feb; 124(2):946-55. PubMed ID: 2536323 [TBL] [Abstract][Full Text] [Related]
11. Binding of Cu2+, Zn2+, and Ni(2+)-GnRH complexes with the rat pituitary receptor. Kochman K; Gajewska A; Kochman H; Kozłowski H; Masiukiewicz E; Rzeszotarska B J Inorg Biochem; 1997 Mar; 65(4):277-9. PubMed ID: 9046108 [TBL] [Abstract][Full Text] [Related]
12. Possible direct effect of gonadotropin releasing hormone on human endometrium and decidua. Takeuchi S; Futamura N; Minoura H; Toyoda N Life Sci; 1998; 62(13):1187-94. PubMed ID: 9519800 [TBL] [Abstract][Full Text] [Related]
13. GnRH receptors and GnRH endocrine effects on luteoma cells. Chamson-Reig A; Lux-Lantos V; Tesone M; Libertun C Endocrine; 1997 Apr; 6(2):165-71. PubMed ID: 9225131 [TBL] [Abstract][Full Text] [Related]
14. Alterations in intracellular messengers mobilized by gonadotropin-releasing hormone in an experimental ovarian tumor. Chamson-Reig A; Pignataro OP; Libertun C; Lux-Lantos VA Endocrinology; 1999 Aug; 140(8):3573-80. PubMed ID: 10433213 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of pure 31-kilodalton bovine inhibin on gonadotropin-releasing hormone (GnRH)-induced up-regulation of GnRH binding sites in cultured rat anterior pituitary cells. Wang QF; Farnworth PG; Findlay JK; Burger HG Endocrinology; 1989 Jan; 124(1):363-8. PubMed ID: 2535810 [TBL] [Abstract][Full Text] [Related]
16. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo. Schubert A; Hawighorst T; Emons G; Gründker C Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682 [TBL] [Abstract][Full Text] [Related]
17. Effects of GnRH analogs on six ovarian cancer cell lines in culture. Connor JP; Buller RE; Conn PM Gynecol Oncol; 1994 Jul; 54(1):80-6. PubMed ID: 8020844 [TBL] [Abstract][Full Text] [Related]
18. Binding properties of solubilized gonadotropin-releasing hormone receptor: role of carboxylic groups. Hazum E Biochemistry; 1987 Nov; 26(22):7011-4. PubMed ID: 2827741 [TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues. Rahimipour S; Ben-Aroya N; Ziv K; Chen A; Fridkin M; Koch Y J Med Chem; 2003 Sep; 46(19):3965-74. PubMed ID: 12954050 [TBL] [Abstract][Full Text] [Related]
20. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells. Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]